Insider · CIK 0001874962
Dannielle Appelhans
director
Files at HALO (HALOZYME THERAPEUTICS, INC.), GBIO (Generation Bio Co.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Restricted Stock Units | +1,161 | $0.00 | $0 | 1,161 | 40 d ago |
| Sep 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Option to Purchase Common Stockderivative | +1,778 | $0.00 | $0 | 1,778 | 40 d ago |
| Feb 9, 2026 | GBIO Generation Bio Co. | UTender of shares Common Stock | -1,263 | - | - | 0 | Feb 9, 2026 |
| Feb 9, 2026 | GBIO Generation Bio Co. | UTender of shares Common Stockindirect: By Spouse | -736 | - | - | 0 | Feb 9, 2026 |
| Feb 9, 2026 | GBIO Generation Bio Co. | DDisposition to issuer Stock Option (right to buy)derivative | -3,000 | - | - | 0 | Feb 9, 2026 |
| Feb 9, 2026 | GBIO Generation Bio Co. | DDisposition to issuer Stock Option (right to buy)derivative | -3,840 | - | - | 0 | Feb 9, 2026 |
| Feb 9, 2026 | GBIO Generation Bio Co. | DDisposition to issuer Stock Option (right to buy)derivative | -2,500 | - | - | 0 | Feb 9, 2026 |
| Feb 9, 2026 | GBIO Generation Bio Co. | DDisposition to issuer Stock Option (right to buy)derivative | -6,000 | - | - | 0 | Feb 9, 2026 |
| Jun 4, 2025 | GBIO Generation Bio Co. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.